VanEck Pharmaceutical ETF (PPH) Short Interest Ratio & Short Volume → We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (From Paradigm Press) (Ad) Free PPH Stock Alerts $92.25 +0.13 (+0.14%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Short Interest DataCurrent Short Interest1,160,000 sharesPrevious Short Interest1,440,000 sharesChange Vs. Previous Month-19.44%Dollar Volume Sold Short$105.22 millionShort Interest Ratio8.2 Days to CoverLast Record DateMay 15, 2024Outstanding Shares5,940,000 sharesPercentage of Shares Shorted19.53%Today's Trading Volume118,020 sharesAverage Trading Volume139,959 sharesToday's Volume Vs. Average84% Short Selling VanEck Pharmaceutical ETF ? Sign up to receive the latest short interest report for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPPH Short Interest Over TimePPH Days to Cover Over TimePPH Percentage of Float Shorted Over Time Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.See all the details you need here. VanEck Pharmaceutical ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,160,000 shares $105.22 million -19.4%N/A8.2 $90.71 4/30/20241,440,000 shares $126.09 million +2.9%N/A9.5 $87.56 4/15/20241,400,000 shares $119.62 million -11.4%N/A11.3 $85.44 3/31/20248,700 shares $789,090.00 -99.5%N/A0.1 $90.70 3/15/20241,570,000 shares $140.59 million -8.7%N/A13 $89.55 2/29/20241,720,000 shares $152.74 million +5.5%N/A14.9 $88.80 Get the Latest News and Ratings for PPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,630,000 shares $144.16 million -22.4%N/A14.9 $88.44 1/31/20242,100,000 shares $179.13 million -0.5%N/A18.6 $85.30 1/15/20242,110,000 shares $180.57 million +14.7%N/A19.3 $85.58 12/31/20231,840,000 shares $149.71 million -4.7%N/A16.5 $81.37 12/15/20231,930,000 shares $152.10 million -18.9%N/A18 $78.81 11/30/20232,380,000 shares $186.85 million -1.2%N/A21.7 $78.51 11/15/20232,410,000 shares $184.75 million +4.3%N/A20.9 $76.66 10/31/20232,310,000 shares $173.97 million +4.5%N/A18.7 $75.31 10/15/20232,210,000 shares $177.00 million -1.3%N/A17.3 $80.09 9/30/20232,240,000 shares $178.89 million -1.3%N/A17.2 $79.86 9/15/20232,270,000 shares $186.03 million -2.6%N/A16.7 $81.95 8/31/20232,330,000 shares $190.83 million +16.5%N/A17.2 $81.90 8/15/20232,000,000 shares $165.46 million -17.0%N/A15.6 $82.73 7/31/20232,410,000 shares $193.81 million -0.4%N/A19.2 $80.42 7/15/20232,420,000 shares $188.49 million +5.2%N/A20.7 $77.89 6/30/20232,300,000 shares $181.17 million +0.4%N/A20.1 $78.77 6/15/20232,290,000 shares $179.70 million +19.9%N/A21.6 $78.47 5/31/20231,910,000 shares $144.49 million -12.8%N/A16.6 $75.65 5/15/20232,190,000 shares $172.48 million -10.3%N/A16.7 $78.76 4/30/20232,440,000 shares $192.44 million +1.2%N/A17.7 $78.87 4/15/20232,410,000 shares $191.59 million +3.9%N/A14.3 $79.50 3/31/20232,320,000 shares $180.10 million +19.0%N/A14.4 $77.63 3/15/20231,950,000 shares $144.65 million -18.8%N/A12.1 $74.18 2/28/20232,400,000 shares $181.56 million +8.1%N/A15.1 $75.65 2/15/20232,220,000 shares $173.74 million -7.5%N/A15.4 $78.26 1/31/20232,400,000 shares $188.02 million -0.4%N/A16.8 $78.34 1/15/20232,410,000 shares $191.60 million +4.8%N/A17.1 $79.50 12/30/20222,300,000 shares $178.80 million -3.8%N/A18.4 $77.74 12/15/20222,390,000 shares $186.68 million +7.2%N/A16 $78.11 11/30/20222,230,000 shares $171.78 million +10.4%N/A14.5 $77.03 11/15/20222,020,000 shares $147.97 million +27.9%N/A12.5 $73.25 10/31/20221,580,000 shares $115.10 million +6.8%N/A10.1 $72.85 10/15/20221,480,000 shares $101.05 million No ChangeN/A8.8 $68.28 9/30/20222,150,000 shares $144.57 million +4.9%N/A13 $67.24The new masters of energy (Ad)According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. 9/15/20222,050,000 shares $144.94 million -10.1%N/A13 $70.70 8/31/20222,280,000 shares $161.29 million +31.0%N/A12.7 $70.74 8/15/20221,740,000 shares $133.18 million +84.7%N/A9.3 $76.54 7/31/2022942,200 shares $72.46 million +45.4%N/A5 $76.90 7/15/2022648,000 shares $49.53 million +12.5%N/A3.8 $76.43 6/30/2022576,100 shares $44.27 million -3.0%N/A3.2 $76.84 6/15/2022593,600 shares $43.62 million +55.3%N/A3.4 $73.49 5/31/2022382,200 shares $30.28 million +1.7%N/A2.7 $79.23 5/15/2022375,700 shares $28.66 million +10.4%N/A3.1 $76.29 4/30/2022340,400 shares $26.40 million -5.6%N/A2.5 $77.55 4/15/2022360,400 shares $29.47 million +25.1%N/A2.7 $81.76 3/31/2022288,100 shares $22.98 million +3.3%N/A2.5 $79.76 3/15/2022279,000 shares $21.28 million +2.2%N/A2.9 $76.28 2/28/2022272,900 shares $20.66 million -6.0%N/A3.1 $75.71 2/15/2022290,300 shares $22.30 million +86.0%N/A3.5 $76.81 1/31/2022156,100 shares $11.84 million +14.7%N/A2.1 $75.85 1/15/2022136,100 shares $10.49 million -29.7%N/A3.1 $77.04 12/31/2021193,500 shares $14.89 million -12.0%N/A4.8 $76.96 12/15/2021219,900 shares $16.53 million +7.3%N/A6.2 $75.19 11/30/2021205,000 shares $14.64 million +0.5%N/A5.9 $71.43 11/15/2021203,900 shares $15.44 million -28.1%N/A6.1 $75.74 10/29/2021283,400 shares $21.30 million -5.6%N/A8.7 $75.15 10/15/2021300,200 shares $21.90 million +0.1%N/A8.8 $72.94 9/30/2021300,000 shares $21.85 million +19.2%N/A5.5 $72.82 9/15/2021251,600 shares $18.58 million +89.7%N/A4.9 $73.83 8/31/2021132,600 shares $10.08 million +2.7%N/A2.8 $76.04 8/13/2021129,100 shares $9.81 million -38.8%N/A2.6 $76.01 7/30/2021211,000 shares $15.80 million -11.6%N/A3.7 $74.86 7/15/2021238,800 shares $17.38 million -14.5%N/A2.6 $72.78 6/30/2021279,400 shares $20.41 million +13.6%N/A2.8 $73.06 6/15/2021245,900 shares $18.29 million +23.8%N/A2.5 $74.36 5/28/2021198,700 shares $14.34 million -20.5%N/A1.5 $72.15 5/14/2021250,000 shares $17.94 million +22.6%N/A1.7 $71.76 4/30/2021204,000 shares $14.25 million -89.3%N/A1.4 $69.87 4/15/20211,910,000 shares $130.30 million +0.5%N/A17.4 $68.22 3/31/20211,900,000 shares $130.91 million +124.6%N/A21.1 $68.90 3/15/2021845,800 shares $58.23 million +102.7%N/A9 $68.85 2/26/2021417,200 shares $28.36 million +22.2%N/A6.7 $67.99 2/12/2021341,300 shares $23.79 million +342.7%N/A7 $69.71 1/29/202177,100 shares $5.35 million -59.3%N/A1.8 $69.34 1/15/2021189,300 shares $13.13 million +22.7%N/A3.3 $69.38 12/31/2020154,300 shares $10.19 million -22.3%N/A2.3 $66.03 12/15/2020198,600 shares $12.97 million +24.7%N/A3.2 $65.29 11/30/2020159,300 shares $10.41 million -7.1%N/A2.3 $65.35 11/15/2020171,500 shares $11.22 million -24.4%N/A2.5 $65.40 10/30/2020226,800 shares $13.41 million -63.9%N/A3.2 $59.11 10/15/2020628,600 shares $39.61 million -4.1%N/A0 $63.02 9/30/2020655,400 shares $40.75 million +195.8%N/A14.5 $62.17 9/15/2020681,900 shares $42.97 million +207.7%N/A15.2 $63.01 8/31/2020221,600 shares $14.30 million -8.2%N/A6.5 $64.53The new masters of energy (Ad)According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. 8/14/2020241,300 shares $15.50 million +18.4%N/A7.8 $64.22 7/31/2020203,800 shares $12.84 million +26.3%N/A7.3 $63.02 7/15/2020161,400 shares $10.12 million +165.0%N/A6.7 $62.71 6/30/202060,900 shares $3.75 million +39.0%N/A1.6 $61.54 6/15/202043,800 shares $2.65 million +177.2%N/A1.1 $60.51 5/29/202015,800 shares $994,294.00 -38.3%N/A0.3 $62.93 5/15/202025,600 shares $1.54 million -1.9%N/A0.3 $59.98 4/30/202026,100 shares $1.58 million -15.5%N/A0.3 $60.56 4/15/202030,900 shares $1.79 million -89.2%N/A0.3 $57.81 3/31/2020287,000 shares $17.27 million -66.0%N/A3.3 $60.16 3/13/2020844,100 shares $48.46 million -65.1%N/A3.8 $57.41 2/28/20202,420,000 shares $115.05 million +4.8%N/A28 $47.54 2/14/20202,310,000 shares $136.01 million +5.5%N/A42.9 $58.88 1/31/20202,190,000 shares $138.23 million -3.1%N/A44.7 $63.12 1/15/20202,260,000 shares $152.37 million +40.4%N/A43.1 $67.42 12/31/20191,610,000 shares $105.17 million -29.1%N/A34.8 $65.32 PPH Short Interest - Frequently Asked Questions What is VanEck Pharmaceutical ETF's current short interest? Short interest is the volume of VanEck Pharmaceutical ETF shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 1,160,000 shares of PPH short. Learn More on VanEck Pharmaceutical ETF's current short interest. What is a good short interest ratio for VanEck Pharmaceutical ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPH shares currently have a short interest ratio of 8.0. Learn More on VanEck Pharmaceutical ETF's short interest ratio. Is VanEck Pharmaceutical ETF's short interest increasing or decreasing? VanEck Pharmaceutical ETF saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 1,160,000 shares, a decrease of 19.4% from the previous total of 1,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Pharmaceutical ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Pharmaceutical ETF: VanEck Biotech ETF (0.11%), Invesco S&P SmallCap Health Care ETF (0.03%), ProShares Ultra Nasdaq Biotechnology (0.74%), Invesco Nasdaq Biotechnology ETF (0.71%), Principal Healthcare Innovators ETF (0.12%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (7.41%), and iShares Biotechnology ETF (16.32%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Pharmaceutical ETF stock? Short selling PPH is an investing strategy that aims to generate trading profit from VanEck Pharmaceutical ETF as its price is falling. PPH shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Pharmaceutical ETF? A short squeeze for VanEck Pharmaceutical ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PPH, which in turn drives the price of the stock up even further. How often is VanEck Pharmaceutical ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPH, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BBH Short Interest Data PSCH Short Interest Data BIB Short Interest Data IBBQ Short Interest Data BTEC Short Interest Data FTXH Short Interest Data JDOC Short Interest Data BIS Short Interest Data IBB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPH) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredNvidia has Apple and Microsoft within striking rangeA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. W...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.